WW's New GLP-1 Drug Platform Boosts Stock
Update: 2025-12-19
Description
Weight Watchers, now WW International, unveils new platform combining GLP-one drugs, personalized plans, and AI-powered body scanner. Post-restructuring, company reduces debt by 70%, raises financial guidance, and sees stock surge. Analysts weigh in on WWs potential as a game-changer in weight management.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel




